Table 2 Therapeutic class for the drug recall data (2010 – January 2019)
From: Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010–January 2019)
No. | No. of occurrence | Class | Occurrence % |
|---|---|---|---|
1 | 23 | Antihypertensive | 27.7 |
2 | 9 | Antibiotics | 10.8 |
3 | 7 | Antidiabetic | 8.4 |
4 | 6 | Non-steroidal anti-inflammatory-analgesic | 7.2 |
5 | 5 | Antiplatelet | 6.1 |
6 | 5 | Bronchodilator-long acting beta agonists | 6.1 |
7 | 4 | Plasma volume expander | 4.8 |
8 | 3 | Statins—anticholesterol | 3.5 |
9 | 3 | Anticancer | 3.5 |
10 | 3 | Antacid | 3.5 |
11 | 3 | Corticosteroids | 3.5 |
12 | 3 | Vitamin | 3.5 |
13 | 2 | Antimicrobial and antiseptic oral rinse | 2.4 |
14 | 2 | Vaccine | 2.4 |
15 | 2 | Antiobesity | 2.4 |
16 | 1 | Anthelmintic | 1.2 |
17 | 1 | Anticonvulsant | 1.2 |
18 | 1 | Antiosteoporotic | 1.2 |
19 | 1 | Local anesthetic | 1.2 |
total | 84 | 19-therapeutic class | 100 |